130 related articles for article (PubMed ID: 37024421)
1. Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients.
Piccinelli ML; Barletta F; Tappero S; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Ahyai S; Longo N; Tilki D; Chun FKH; Terrone C; Briganti A; de Cobelli O; Musi G; Karakiewicz PI
Eur Urol Focus; 2023 Sep; 9(5):799-806. PubMed ID: 37024421
[TBL] [Abstract][Full Text] [Related]
2. Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma.
Piccinelli ML; Morra S; Tappero S; Cano Garcia C; Barletta F; Incesu RB; Scheipner L; Baudo A; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Carmignani L; Ahyai S; Tilki D; Briganti A; Chun FKH; Terrone C; Longo N; de Cobelli O; Musi G; Karakiewicz PI
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046815
[TBL] [Abstract][Full Text] [Related]
3. External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population.
Lee HJ; Lee A; Huang HH; Lau WKO
Urol Oncol; 2019 Jun; 37(6):356.e9-356.e18. PubMed ID: 30905510
[TBL] [Abstract][Full Text] [Related]
4. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
[TBL] [Abstract][Full Text] [Related]
5. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma.
Piccinelli ML; Tappero S; Cano Garcia C; Barletta F; Incesu RB; Morra S; Scheipner L; Tian Z; Luzzago S; Mistretta FA; Ferro M; Saad F; Shariat SF; Ahyai S; Longo N; Tilki D; Briganti A; Chun FKH; Terrone C; de Cobelli O; Musi G; Karakiewicz PI
Eur Urol Open Sci; 2023 Jul; 53():109-115. PubMed ID: 37441347
[TBL] [Abstract][Full Text] [Related]
7. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.
Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
Urol Oncol; 2021 Dec; 39(12):835.e19-835.e27. PubMed ID: 34620554
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
10. Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort.
Zastrow S; Brookman-May S; Cong TA; Jurk S; von Bar I; Novotny V; Wirth M
World J Urol; 2015 Mar; 33(3):381-8. PubMed ID: 24850226
[TBL] [Abstract][Full Text] [Related]
11. External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Zastrow S; Krabbe LM; Wolff I; Capitanio U; Klatte T; Ecke T; Huck N; Borgmann H; Scavuzzo A; Cindolo L; Schips L; Surcel C; Mirvald C; Cabo AV; Musquera M; Hutterer G; Prochazkova K; Stief C; Wirth M; May M; Brookman-May S
Int J Clin Oncol; 2020 Jan; 25(1):145-150. PubMed ID: 31471787
[TBL] [Abstract][Full Text] [Related]
12. A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study.
Wang J; Tang J; Chen T; Yue S; Fu W; Xie Z; Liu X
J Transl Med; 2022 Feb; 20(1):90. PubMed ID: 35164796
[TBL] [Abstract][Full Text] [Related]
13. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
Klatte T; Remzi M; Zigeuner RE; Mannweiler S; Said JW; Kabbinavar FF; Haitel A; Waldert M; de Martino M; Marberger M; Belldegrun AS; Pantuck AJ
J Urol; 2010 Jul; 184(1):53-8. PubMed ID: 20478577
[TBL] [Abstract][Full Text] [Related]
15. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
Front Public Health; 2022; 10():989566. PubMed ID: 36276376
[TBL] [Abstract][Full Text] [Related]
16. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
[TBL] [Abstract][Full Text] [Related]
17. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
18. Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation.
Nocera L; Collà Ruvolo C; Stolzenbach LF; Wenzel M; Tian Z; Larcher A; Capitanio U; Mirone V; Tilki D; Chun FKH; Kapoor A; Shariat SF; Saad F; Montorsi F; Briganti A; Karakiewicz PI
Eur Urol Focus; 2022 Jan; 8(1):182-190. PubMed ID: 33653677
[TBL] [Abstract][Full Text] [Related]
19. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma.
Karakiewicz PI; Suardi N; Capitanio U; Jeldres C; Ficarra V; Cindolo L; de la Taille A; Tostain J; Mulders PF; Bensalah K; Artibani W; Salomon L; Zigeuner R; Valéri A; Descotes JL; Rambeaud JJ; Méjean A; Montorsi F; Bertini R; Patard JJ
Eur Urol; 2009 Feb; 55(2):287-95. PubMed ID: 18715700
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules.
Adibi M; Kenney PA; Thomas AZ; Borregales LD; Nogueras-González GM; Wang X; Devine CE; Karam JA; Wood CG
Eur Urol; 2016 Feb; 69(2):352-60. PubMed ID: 26382085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
